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The enzyme l-aminoacylase catalyses the hydrolysis of N-acyl-
l-amino acids from peptides or proteins. The recombinant enzyme
from the hyperthermophilic archaeon Thermococcus litoralis has
been puri®ed to homogeneity. This zinc-containing enzyme has been
crystallized from ammonium sulfate using the sitting-drop vapour-
diffusion method. The crystals diffract to 2.8 AÊ resolution and belong
to the rhombohedral space group R32, with unit-cell parameters
a = b = 102.4, c = 178.5 AÊ ,  = 120 in a hexagonal lattice setting. The
asymmetric unit contains one enzyme monomer, containing a single
zinc ion. Two synchrotron data sets have been collected at a remote
wavelength and at the maximum f 0 wavelength for zinc. This has
allowed the position of the metal to be identi®ed in anomalous
Patterson maps.
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1. Introduction
Aminoacylase I (N-acylamino acid amido-
hydrolase; EC 3.5.1.14) catalyses the hydrolysis
of N-acyl-l-amino acids from peptides or
proteins. Aminoacylase I has been identi®ed in
eukaryotic species as well as eubacteria and
archaea. Although these enzymes have been
known for many years, their physiological role
is still not fully understood. It has been
proposed that they are involved in the cata-
bolism of terminal N-acyl peptides or in the
recycling of N-acylated amino acids (Gade &
Brown, 1981). Aminoacylases are known to
play a role in xenobiotic detoxication and
bioactivation and are important in the inter-
organ processing of xenobiotic derived amino-
acid conjugates. Mercapturates (S-substituted
N-acetyl-l-cysteine conjugates), which are
formed by the acetylation of l-cysteine-
S-conjugates obtained from the hydrolysis of
glutathione-S-conjugates, are cleaved by
aminoacylases (Anders & Dekant, 1994).
Human aminoacylase I has been assigned to
distal chromosome 3p21.1. This region is
deleted in several neoplasms, including small-
cell lung cancer (Scaloni et al., 1992) and renal
cell carcinoma. It has been suggested that
the acylase I and small-cell cancer tumour
suppressor genes are closely linked (Miller et
al., 1989) and that the processing of N-acylated
peptides may in¯uence growth regulation
(Tsunasawa, 1992).
The mammalian aminoacylases are the most
extensively studied, with the enzymes from
human (Cook et al., 1993) and pig (Birnbaum
et al., 1952) being characterized. The major
interest in the bacterial/archaeal enzymes is
their importance industrially, as they can be
used for resolution of racemic N-acylated
amino acids (Chenault et al., 1989). Amino-
acid sequence identity between the members
of the aminoacylase I family is low; mammalian
enzymes show only 12% identity to eubacterial
and archaeal aminoacylases. However, the
amino-acid residues proposed to be involved in
metal binding are conserved throughout the
family. All of the aminoacylases characterized
to date are homodimers with a subunit
molecular weight between 42 and 45 kDa,
containing one zinc ion per subunit. It was
generally thought that this zinc was involved
directly in enzymatic catalysis as a Lewis acid;
however, there is a growing consensus that it
plays only a structural role (Heese et al., 1990).
Paramagnetic and kinetic studies on the
porcine kidney aminoacylase suggest that the
metal centre is too far from the ligand-binding
site to be involved directly in substrate binding
or catalysis (Heese et al., 1990). It has been
proposed that the presence of the metal ion
helps to maintain the conformation of the
active site in a strained state ± the entactic state
required for catalysis (Weiss et al., 1995).
Studies involving circular dichroism and
FT-Raman spectroscopy (Tang et al., 1995)
have shown that there is a difference between
the holoenzyme and the apoenzyme amino-
acylase structures, since removal of the zinc
results in a decrease in the extent of ordered
structure.
The hyperthermophilic archaeal T. litoralis
l-aminoacylase has been cloned and over-
expressed in Escherichia coli (Toogood et al.,
2002). The molecular mass of the enzyme was
calculated to be 43 814 Da according to its
sequence. The T. litoralis l-aminoacylase is
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thermostable, with a half-life of 25 h at
343 K. This makes it suitable for industrial
biotransformation reactions at elevated
temperatures.
The T. litoralis l-aminoacylase has
82% sequence identity to a bifunctional
carboxypeptidase/aminoacylase from Pyro-
coccus horikoshii OT3 (Ishikawa et al., 2001)
and 45% sequence identity to a carboxy-
peptidase from Sulfolobus solfataricus
(Colombo et al., 1995). However, the
T. litoralis enzyme does not exhibit detect-
able carboxypeptidase activity (Toogood et
al., 2002).
A zinc carboxypeptidase G2 from
Pseudomonas sp. strain RS-16 for which the
three-dimensional structure is available
(Rowsell et al., 1997) has a distant sequence
similarity (17% amino-acid identity) to the
T. litoralis l-aminoacylase. The overall
sequence identity between these two
enzymes is low; however, reiterative BLAST
search (Altschul et al., 1997) analysis
suggests they are both members of the same
protein family, peptidase M20. Carboxy-
peptidase has two zinc ions bound in this
region, whereas the aminoacylase has only
one.
There is no three-dimensional informa-
tion available for any aminoacylase enzyme
to date and therefore the elucidation of the
X-ray structure of the T. litoralis enzyme will
further our understanding of the catalytic
mechanism and evolution of this group of
metalloproteins.
2. Materials and methods
2.1. Protein purification
The aminoacylase protein was puri®ed
from E. coli harbouring the gene for the
enzyme in the overexpression vector
pUCcer11 (Toogood et al., 2002). E. coli cells
containing the expressed protein were
resuspended in 40 ml 100 mM Tris±HCl pH
8.0 and sonicated for 2 min on ice. The
insoluble cell debris was removed by
centrifugation at 30 000g and the super-
natant was decanted into a sterile universal
tube and heated to 343 K in a water bath for
20 min. The precipitated protein was
removed by centrifugation at 30 000g for
30 min at 277 K.
Ammonium sulfate (enzyme grade) was
added slowly to the supernatant to
60%(w/v) saturation with continuous stir-
ring. The precipitated protein was removed
by centrifugation (10 000g, 20 min) and
redissolved in 10 ml 100 mM Tris±HCl pH
8.0, 0.4 M ammonium sulfate (buffer A)
before application to a hydrophobic inter-
action chromatography column (phenyl
Sepharose CL 4B, Pharmacia) pre-equili-
brated with buffer A. An isocratic gradient
was carried out over ®ve column volumes
leading to 100% buffer B (30% 2-propanol,
10 mM Tris±HCl pH 8.0) at a ¯ow rate of
2 ml minÿ1 and was collected in 10 ml frac-
tions. Active fractions were pooled and
dialysed against 5 l of 10 mM Tris±HCl pH
8.0 (buffer C) overnight. The protein was
precipitated with 80% ammonium sulfate,
centrifuged at 10 000g for 20 min and
redissolved in 2 ml of buffer C and applied
to a gel-®ltration column (Superdex 200
Hiload 16/60, Pharmacia) pre-equilibrated
with buffer C. Protein was eluted with buffer
C at 0.7 ml minÿ1 and collected in 5 ml
fractions. All puri®cation steps were carried
out at 277 K unless otherwise stated. All
buffers contained 1  10ÿ5 M phenyl-
methylsulfonyl ¯uoride and 2  10ÿ5 M
benzamidine as protease inhibitors. The
purity of the protein was analysed by SDS±
PAGE and the concentration of the protein
was determined by the Bradford assay
(Bradford, 1976). Bovine serum albumin
(Sigma±Aldrich Co.) was used to generate a
standard curve.
2.2. Enzyme activity
l-Aminoacylase activity was determined
by an HPLC method. The substrate N-Ac-
dl-tryptophan was used in the aminoacylase
activity because of its ease of detection. The
reaction mixture contained 0.89 ml 0.1 M
Tris±HCl pH 8.0, 100 ml 100 mM N-Ac-dl-
Trp and 10 ml of enzyme combined in a
microcentrifuge tube which was incubated at
the required temperature for 1 h. The re-
action was stopped by addition of 1 ml
200 mM EDTA. A 100 ml aliquot of the
stopped reaction mixture was added to
900 ml of HPLC mobile phase (45%
methanol, 1 ml lÿ1 H3PO4) and mixed. An
aliquot of 1 ml was injected into a Hypersil
C18 BDS column using a Beckman System
Gold HPLC with a ¯ow rate of 2.0 ml minÿ1
using a run time of 4 min and a detection
wavelength of 225 nm. The substrate reten-
tion time was 3.02 min and the product
1.98 min.
2.3. Sedimentation equilibrium analysis
Sedimentation equilibrium analysis of the
puri®ed l-aminoacylase enzyme was carried
out by the BBSRC National Centre for
Macromolecular Hydrodynamics, University
of Nottingham, UK. The l-aminoacylase
sample was monitored by sedimentation
equilibrium at concentrations of 0.5 and
1 mg mlÿ1 in the buffer 10 mM Tris±HCl pH
7.0.
2.4. Crystallization
Crystallization was carried out by the
method of sitting-drop vapour diffusion.
Prior to crystallization, the protein was
concentrated using 30 kDa molecular-
weight cutoff Microsep microconcentrators
(Filtron Technology Corp., Northborough,
MA, USA) to 7.5 mg mlÿ1 in 10 mM
Tris±HCl pH 8.0. 2 ml aliquots of protein
solution were mixed with 2 ml of the reser-
voir solution. The reservoir contained 47%
(saturation) ammonium sulfate, 100 mM
MES pH 6.0, 1% -octyl glucoside.
2.5. Crystallographic data collection
Data were collected at the DESY
Synchrotron, Hamburg, EMBL station
BW7A using a single cryocooled crystal at
100 K and a MAR Research CCD detector.
The cryogenic liquor consisted of 57%
(saturation) ammonium sulfate, 30%(v/v)
glycerol, 100 mM MES pH 6.0 and 1%
-octyl glucoside. The data were collected at
a remote wavelength of 0.9793 AÊ and at a
maximal f 0 wavelength for zinc of 1.2824 AÊ .
3. Results and discussion
The puri®ed recombinant l-aminoacylase
migrated on SDS±PAGE as a single band of
43 kDa. However, gel-®ltration analysis
carried out in 10 mM Tris±HCl pH 8.0 esti-
mated the size of the enzyme to be 170 kDa,
Figure 1
Rhombohedral crystals of recombinant T. litoralis
l-aminoacylase. Typical dimensions are approxi-
mately 0.1  0.1  0.2 mm.
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suggesting that the enzyme exists
as a homotetramer. The sedi-
mentation studies carried out at
0.5 and 1 mg mlÿ1 in 10 mM
Tris±HCl pH 7.0 also showed
that the enzyme exists predomi-
nantly as a tetramer. The speci®c
activity using the substrate N-
Ac-dl-Trp was found to be
0.2 mmol minÿ1 per milligram of
protein.
A shower of crystals was
formed when crystallization was
carried out in the absence of -
octyl glucoside. Addition of the
detergent decreased the amount
of nucleation, subsequently increasing the
size of the crystals. Crystals grew in 1±2 d
and reached dimensions of 0.1  0.1 
0.2 mm (Fig. 1). The crystals diffracted to
2.8 AÊ using synchrotron radiation and
belonged to the rhombohedral space group
R32, with unit-cell parameters a = b = 102.4,
c = 178.5 AÊ ,  = 120 in the hexagonal lattice
setting, a = b = c = 83.9 AÊ , =  =  = 75.3 in
the rhombohedral lattice setting.
Data were processed using the programs
DENZO and SCALEPACK (Otwinowski &
Minor, 1997). A summary of the X-ray data
statistics is shown in Table 1. A twinning test
using the program SFCHECK (Vaguine
et al., 1999) gave average values of
hI2i/hIi2 = 1.97, suggesting the crystal was not
twinned, a possibility in the R32 space
group. The solvent content of the crystals
that contain a monomer in the asymmetric
unit has been estimated at 41%, with
VM = 2.06 AÊ
3 Daÿ1 (Matthews, 1968). It is
possible, owing to the high salt content of
the crystallization solution, that intersubunit
ionic bonds could have been disrupted,
resulting in a monomer or a dimer in the
crystal rather than the tetramer observed in
solution studies. A tetramer would be
inconsistent with the observed crystallo-
graphic symmetry.
The position of the zinc in the asymmetric
unit has been found in the anomalous
difference Patterson map using data
collected at a wavelength of 1.2824 AÊ in the
resolution range 15±5 AÊ using the program
RSPS (Collaborative Computational
Project, Number 4, 1994). The resulting zinc
ion fractional coordinates are (x, y, z) =
(0.512, 0.483, 0.144), which agree with the
anomalous difference Patterson maps
calculated with Fourier coef®cients
(Frÿ kF1)2 (Fig. 2) and (F1+ÿ F1ÿ)2 (Fig. 3),
where Fr is the structure factor at a remote
wavelength, F1 is the structure factor at the
maximal f 0 wavelength for zinc of 1.2824 AÊ
and k is the scale coef®cient. Heavy-atom
re®nement and phasing was performed in
parallel by MLPHARE (Collaborative
Computational Project, Number 4, 1994),
SHARP (de La Fortelle & Bricogne, 1997)
and by the fast maximum-likelihood heavy-
atom re®nement algorithm (A. Lebedev,
unpublished data). The phases from SHARP
and the fast maximum-likelihood heavy-
atom re®nement algorithm had a difference
of 60. The phases obtained from
MLPHARE were not consistent with any
other phases. Density modi®cation of the
phases from the fast maximum-likelihood
heavy-atom re®nement algorithm was
performed using the program DM (Cowtan,
1994). Some short -helices and a -sheet
could be observed in the resulting synthesis,
which allowed the determination of the hand
of the map. Phases from SHARP were
modi®ed using the program SOLOMON
(Abrahams & Leslie, 1996). Several
secondary-structure elements could be also
observed in the resulting synthesis.
However, the quality of neither of the two
maps was good enough to trace the
aminoacylase main chain.
The molecular-replacement studies were
carried out with the programs MOLREP
(Vagin & Teplyakov, 1997) and AMoRe
(Navaza, 1994) using the whole structure or
the two separate domains of carboxy-
peptidase G2 (Rowsell et al., 1997). The
molecular-replacement approach has so far
failed to ®nd a solution that could be re®ned.
Phased molecular replacement is currently
being attempted using the anomalous phases
and the carboxypeptidase G2 structure with
the program MOLREP (Vagin & Teplyakov,
1997). In addition, heavy-atom derivatives
are also being employed in an effort to solve
the structure of this aminoacylase enzyme.
This work was supported by the Biotech-
nology and Biological Sciences Research
Council as a studentship to EJH and a
Table 1
Processing statistics for native and anomalous data sets.
Values in parentheses are for the highest resolution shell.
Data set
Parameter Native Anomalous
Wavelength (AÊ ) 0.9793 1.2824
Oscillation range () 0.5 0.5
Resolution range (AÊ ) 15±2.9 (2.95±2.9) 15±3.0 (3.04±3.0)
No. of measured re¯ections 26083 30612
No. of unique re¯ections 7218 7354
Completeness (%) 88.7 (93.0) 99.7 (100.0)
I > 2(I) (%) 72.7 85
hIi/hIi 17.8 15.8
Rsym² (%) 6.1 (49.7) 7.7 (53.5)
² Rsym =
P jI ÿ hIij/P I, where I is the intensity of re¯ection.
Figure 2
w = 0 section of the anomalous difference Patterson
synthesis calculated with Fourier coef®cients
(Fr ÿ kF1)2 at 10±5 AÊ resolution, where Fr is the
structure factor at a remote wavelength, F1 is the
structure factor at a maximal f 0 wavelength for zinc of
1.2824 AÊ and k is the scale coef®cient.
Figure 3
w = 0.066 section of the anomalous difference
Patterson synthesis calculated at 10±5 AÊ resolution
with Fourier coef®cients (F1+ÿ F1ÿ)2, where F1 is the
structure factor at a maximal f 0 wavelength for zinc of
1.2824 AÊ .
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